Induced labour – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Fri, 12 Jun 2026 11:13:52 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Induced labour – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Comparison of Oxytocin versus Prostaglandins (Dinoprostone and Misoprostol) for Labor Induction in Women with Unfavorable Cervix After Initial Cervical Ripening https://clinicaltrials.eu/trial/study-on-oxytocin-and-prostaglandins-for-inducing-labor-in-women-with-unfavorable-cervix-after-24-hours-of-cervical-ripening/ Wed, 29 Apr 2026 15:02:25 +0000 https://clinicaltrials.eu/trial/study-on-oxytocin-and-prostaglandins-for-inducing-labor-in-women-with-unfavorable-cervix-after-24-hours-of-cervical-ripening/ This study focuses on labor induction in pregnant women who have an unfavorable cervix after initial cervical ripening treatment. The research compares two different approaches to inducing labor: using oxytocin versus continuing with prostaglandins. The purpose is to determine if using oxytocin is as effective as prostaglandins for labor induction after the first 24 hours of cervical preparation.

The medications being studied include Oxytocine Panpharma, which is given through an intravenous injection, and several prostaglandin preparations: Propess (vaginal delivery system), Prostine E2 (vaginal gel), and Angusta (oral tablet). These medications are commonly used to help start and progress labor in pregnant women whose cervix is not yet ready for delivery.

During the study, women will receive either oxytocin through an IV or one of the prostaglandin medications after their initial cervical ripening treatment has been completed. The study will track various outcomes related to the delivery process and the health of both mother and baby, with special attention to the rate of cesarean delivery. The research will also evaluate factors such as the time until delivery and any complications that may occur during the process.

]]> Study on Misoprostol for Inducing Labor in Pregnant Women: Comparing Outpatient and Inpatient Settings https://clinicaltrials.eu/trial/study-on-misoprostol-for-inducing-labor-in-pregnant-women-comparing-outpatient-and-inpatient-settings/ Wed, 29 Apr 2026 14:26:27 +0000 https://clinicaltrials.eu/trial/study-on-misoprostol-for-inducing-labor-in-pregnant-women-comparing-outpatient-and-inpatient-settings/ This clinical trial is focused on the process of inducing labor, which is when medical methods are used to help start childbirth. The study is examining the use of a medication called misoprostol, which is taken as a tablet. The purpose of the study is to determine if inducing labor at home is as safe and effective as doing it in a hospital setting.

Participants in the study will be randomly assigned to either have their labor induced at home or in the hospital. The study will monitor the safety and effectiveness of both methods by looking at outcomes such as the health of the mother and baby, the method of delivery, and the experiences of the women and their partners. The study will also gather information on the cost-effectiveness of each method and the experiences of healthcare staff involved in the process.

The trial aims to provide valuable insights into whether home-based labor induction can be a safe and effective option for expectant mothers, potentially offering more flexibility and comfort during the childbirth process. The study will continue until the end of 2028, with results being collected and analyzed to help inform future practices in labor induction.

]]>